Debiopharm Innovation Fund’s objective is to make strategic investments in innovative companies with technologies and business models that change the way they develop drugs and treat patients.
They bring value to their portfolio companies through their knowledge in medicine, pharmaceutical development, regulatory/reimbursement aspects, management and expertise in bringing products to market. They drive their portfolio investments to successful exits.